Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer
Authors:
- 13 March 2015
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 404 (1-2) , 251-257
Abstract
High mobility group A1 (HMGA1), as a major member of HMGA family, plays an important part in promotion of cell proliferation and motility, induction of epithelial-mesenchymal transition, and maintenance of stemness, but little is known about the pathological role of HMGA1 in breast cancer patients. The aim of this study was to identify the pathological roles of HMGA1 in breast cancer. In our results, we found that mRNA and protein expression levels of HMGA1 were markedly higher in breast cancer tissues than in normal breast tissues. Using immunohistochemistry, high levels of HMGA1 protein were positively correlated with the status of histological grade (I–II vs. III–IV; P = 0.023), clinical stage (I–II vs. III–IV; P = 0.008), tumor size (T1–T2 vs. T3–T4; P = 0.015), lymph node metastasis (N0–N1 vs. N2–N3; P = 0.002), distant metastasis (M0 vs. M1; P < 0.001), and triple-negative breast cancer (No vs. Yes; P = 0.014) of breast cancer patients. Patients with higher HMGA1 expression had a significantly shorter overall survival time than did patients with low HMGA1 expression. Multivariate analysis indicated that the level of HMGA1 expression was an independent prognostic indicator (P < 0.001) for the survival of patients with breast cancer. In conclusion, HMGA1 plays an important role on breast cancer aggressiveness and prognosis and may act as a promising target for prognostic prediction.Keywords
This publication has 27 references indexed in Scilit:
- Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinomaCell Death & Disease, 2013
- Overexpression of High Mobility Group A1 Protein in Human Uveal Melanomas: Implication for PrognosisPLOS ONE, 2013
- HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer CellsPLOS ONE, 2013
- Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancerEuropean Journal of Cancer, 2010
- Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanismInternational Journal of Cancer, 2010
- Increased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomasHistopathology, 2010
- HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinomaLaboratory Investigation, 2010
- Signalling to chromatin through post-translational modifications of HMGNBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Determination of High Mobility Group A1 (HMGA1) Expression in Hepatocellular Carcinoma: A Potential Prognostic MarkerDigestive Diseases and Sciences, 2005
- HMGA1 Protein Overexpression in Human Breast CarcinomasClinical Cancer Research, 2004